LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment
March 30, 2021
Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...
itolizumab
LRA Shares Excitement For What’s Ahead in Lupus Nephritis
January 16, 2020
Up to half of people with lupus will have lupus nephritis – damage to the kidneys that...
LRA Celebrates Major Research Breakthroughs in 2019
January 7, 2020
2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science...
Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA
December 10, 2019
The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...
LRA Applauds Exciting Lupus Research Being Presented at 2019 ACR/ARP Annual Meeting
Includes 16 presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways
Results...